)
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Sanket Koul is a mass communication graduate with a PG diploma in English Journalism from IIMC Delhi. As a correspondent at Business Standard, he covers the pulse of the social sector, from industry and institutional developments, to the government's latest moves in education, healthcare, pharmaceuticals and medical devices sectors.
Poly Medicure will acquire Italy's Citieffe Group for Rs 324 crore, gaining entry into the global orthopaedics market and expanding its overseas footprint after PendraCare
Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore market opportunity from FY26 onwards
The Union Cabinet has approved Rs 15,034 crore schemes to add 10,000 undergraduate and postgraduate medical seats by 2028-29 through upgradation of government colleges
ONE Group Developers launches The Clermont in Mohali with 216 units, projected revenue of ₹400 crore and modern aluminium formwork technology for quality and timely delivery
The Education Ministry and Atal Innovation Mission launched Viksit Bharat Buildathon to mobilise over one crore students from 1.5 lakh schools for innovation and problem-solving
The US drug regulator flagged concerns over acetaminophen use in pregnancy, citing studies linking it to autism and ADHD, while noting no proven causal relationship
Real estate developers expect GST cuts on inputs and festive buying sentiment to spur housing demand across luxury, mid-segment and Tier-2 cities after a lull in sales
If H-1B visas become harder to secure, the OPT period risks being viewed as a temporary stopgap rather than a pathway to stable employment
In May this year, NAR India had directed its members to cease all listings, advertisements, and business transactions with MagicBricks and avoid all engagement with the platform
India has topped the global flex office maturity index, with Cushman and Wakefield projecting stock to cross 100 mn sq ft by 2026 on strong demand and operator expansion
CDSCO flagged three spurious drugs, including Pan D, Pan 40 and diazepam injection, and listed 94 medicines as not of standard quality in its August 2025 surveillance update
Metropolis added that the move is expected to enhance productivity and drive overall profitability across its network of laboratories operating in the region
ICRA projects Indian pharma firms' US revenue growth to slow due to price erosion, USFDA scrutiny and tariff risks, while high dependence on Chinese APIs persists despite PLI
"GPT-powered dashboards will be used to provide real-time, data-driven insights across R&D, supply chain and commercial operations," a company executive told Business Standard
The simmering conflict came to a head last month when Niva Bupa suspended cashless services at Max Hospitals on August 16, citing unresolved reimbursement issues
Industry body Aimed says proposed balanced reforms could help reduce healthcare costs for consumers
The National Medical Commission has approved 6,850 new MBBS seats for 2025-26, aligning with the Centre's plan to expand medical education and improve India's doctor-patient ratio
2-judge Bench issued a wide-ranging set of 12 binding directions, including framing of specific guidelines for insolvency proceedings in real estate
NPPA directs pharma and medical device makers to revise MRPs after GST cut to 5 per cent, while making relabelling of old stock voluntary subject to compliance
Legal experts caution of challenge in SC, also clarity would be needed for settling ITC